247 related articles for article (PubMed ID: 23669347)
1. The lysosomal inhibitor, chloroquine, increases cell surface BMPR-II levels and restores BMP9 signalling in endothelial cells harbouring BMPR-II mutations.
Dunmore BJ; Drake KM; Upton PD; Toshner MR; Aldred MA; Morrell NW
Hum Mol Genet; 2013 Sep; 22(18):3667-79. PubMed ID: 23669347
[TBL] [Abstract][Full Text] [Related]
2. Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells.
Yang J; Li X; Li Y; Southwood M; Ye L; Long L; Al-Lamki RS; Morrell NW
Am J Physiol Lung Cell Mol Physiol; 2013 Aug; 305(4):L312-21. PubMed ID: 23771884
[TBL] [Abstract][Full Text] [Related]
3. Chloroquine prevents progression of experimental pulmonary hypertension via inhibition of autophagy and lysosomal bone morphogenetic protein type II receptor degradation.
Long L; Yang X; Southwood M; Lu J; Marciniak SJ; Dunmore BJ; Morrell NW
Circ Res; 2013 Apr; 112(8):1159-70. PubMed ID: 23446737
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-β(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3.
Upton PD; Davies RJ; Tajsic T; Morrell NW
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1135-45. PubMed ID: 23937428
[TBL] [Abstract][Full Text] [Related]
5. Failure of bone morphogenetic protein receptor trafficking in pulmonary arterial hypertension: potential for rescue.
Sobolewski A; Rudarakanchana N; Upton PD; Yang J; Crilley TK; Trembath RC; Morrell NW
Hum Mol Genet; 2008 Oct; 17(20):3180-90. PubMed ID: 18647753
[TBL] [Abstract][Full Text] [Related]
6. Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension.
Long L; Ormiston ML; Yang X; Southwood M; Gräf S; Machado RD; Mueller M; Kinzel B; Yung LM; Wilkinson JM; Moore SD; Drake KM; Aldred MA; Yu PB; Upton PD; Morrell NW
Nat Med; 2015 Jul; 21(7):777-85. PubMed ID: 26076038
[TBL] [Abstract][Full Text] [Related]
7. Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo.
Yang J; Li X; Al-Lamki RS; Southwood M; Zhao J; Lever AM; Grimminger F; Schermuly RT; Morrell NW
Circ Res; 2010 Jul; 107(2):252-62. PubMed ID: 20522807
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells.
Upton PD; Davies RJ; Trembath RC; Morrell NW
J Biol Chem; 2009 Jun; 284(23):15794-804. PubMed ID: 19366699
[TBL] [Abstract][Full Text] [Related]
9. Endothelial
Theilmann AL; Hawke LG; Hilton LR; Whitford MKM; Cole DV; Mackeil JL; Dunham-Snary KJ; Mewburn J; James PD; Maurice DH; Archer SL; Ormiston ML
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2605-2618. PubMed ID: 32998516
[TBL] [Abstract][Full Text] [Related]
10. Regulation of bone morphogenetic protein signalling in human pulmonary vascular development.
Southwood M; Jeffery TK; Yang X; Upton PD; Hall SM; Atkinson C; Haworth SG; Stewart S; Reynolds PN; Long L; Trembath RC; Morrell NW
J Pathol; 2008 Jan; 214(1):85-95. PubMed ID: 17992660
[TBL] [Abstract][Full Text] [Related]
11. BMP type II receptor deficiency confers resistance to growth inhibition by TGF-β in pulmonary artery smooth muscle cells: role of proinflammatory cytokines.
Davies RJ; Holmes AM; Deighton J; Long L; Yang X; Barker L; Walker C; Budd DC; Upton PD; Morrell NW
Am J Physiol Lung Cell Mol Physiol; 2012 Mar; 302(6):L604-15. PubMed ID: 22227206
[TBL] [Abstract][Full Text] [Related]
12. The transforming growth factor-β-bone morphogenetic protein type signalling pathway in pulmonary vascular homeostasis and disease.
Upton PD; Morrell NW
Exp Physiol; 2013 Aug; 98(8):1262-6. PubMed ID: 23645549
[TBL] [Abstract][Full Text] [Related]
13. Identification of MicroRNA-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 (Polypyrimidine Tract Binding Protein) and Pyruvate Kinase M2.
Caruso P; Dunmore BJ; Schlosser K; Schoors S; Dos Santos C; Perez-Iratxeta C; Lavoie JR; Zhang H; Long L; Flockton AR; Frid MG; Upton PD; D'Alessandro A; Hadinnapola C; Kiskin FN; Taha M; Hurst LA; Ormiston ML; Hata A; Stenmark KR; Carmeliet P; Stewart DJ; Morrell NW
Circulation; 2017 Dec; 136(25):2451-2467. PubMed ID: 28971999
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension.
Dewachter L; Adnot S; Guignabert C; Tu L; Marcos E; Fadel E; Humbert M; Dartevelle P; Simonneau G; Naeije R; Eddahibi S
Eur Respir J; 2009 Nov; 34(5):1100-10. PubMed ID: 19324947
[TBL] [Abstract][Full Text] [Related]
15. Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells.
Awad KS; Elinoff JM; Wang S; Gairhe S; Ferreyra GA; Cai R; Sun J; Solomon MA; Danner RL
Am J Physiol Lung Cell Mol Physiol; 2016 Jan; 310(2):L187-201. PubMed ID: 26589479
[TBL] [Abstract][Full Text] [Related]
16. BMPR-II deficiency elicits pro-proliferative and anti-apoptotic responses through the activation of TGFβ-TAK1-MAPK pathways in PAH.
Nasim MT; Ogo T; Chowdhury HM; Zhao L; Chen CN; Rhodes C; Trembath RC
Hum Mol Genet; 2012 Jun; 21(11):2548-58. PubMed ID: 22388934
[TBL] [Abstract][Full Text] [Related]
17. TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling.
Hurst LA; Dunmore BJ; Long L; Crosby A; Al-Lamki R; Deighton J; Southwood M; Yang X; Nikolic MZ; Herrera B; Inman GJ; Bradley JR; Rana AA; Upton PD; Morrell NW
Nat Commun; 2017 Jan; 8():14079. PubMed ID: 28084316
[TBL] [Abstract][Full Text] [Related]
18. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of leukocyte recruitment via CXCR1/2 inhibition stops the progression of PAH in mice with genetic ablation of endothelial BMPR-II.
Burton VJ; Holmes AM; Ciuclan LI; Robinson A; Roger JS; Jarai G; Pearce AC; Budd DC
Blood; 2011 Oct; 118(17):4750-8. PubMed ID: 21900197
[TBL] [Abstract][Full Text] [Related]
20. Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertension.
Nasim MT; Ghouri A; Patel B; James V; Rudarakanchana N; Morrell NW; Trembath RC
Hum Mol Genet; 2008 Jun; 17(11):1683-94. PubMed ID: 18321866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
